In a systematic review and meta-analysis examining orlistat use in women with PCOS, orlistat was found to be associated in most studies with a significant improvement in insulin sensitivity with a decrease in HOMA IR and/or insulin levels, as well as a significant reduction in testosterone levels [107]. The gene discussed is INS; the disease is polycystic ovary syndrome.